AMI eyes

Key Takeaways

AMI Eyes is a PDRN-based skin booster specifically formulated for the delicate periorbital area to treat dark circles, fine lines, and under-eye hollowing.

AMI Eyes requires structured treatment documentation including patient screening for salmon DNA allergy, contraindication assessment, and injection technique recording.

Treatment involves 3 sessions at 2-4 week intervals, with room-temperature storage (do not freeze) and clear aftercare protocols to maximize patient outcomes.

Pabau’s digital consent forms and medical notes allow practitioners to document AMI Eyes treatments systematically, link injection points to patient records, and automate aftercare messaging.

AMI Eyes is a polynucleotide (PDRN) skin booster injection treatment designed for the periorbital area. Whether you’re offering this treatment in an aesthetic practice, dermatology practice, or medical spa, having a structured, legally compliant consent form and treatment protocol in place protects both you and your patients.

This guide covers everything aesthetic practitioners need to understand about AMI Eyes treatment documentation, contraindication screening, and the clinical templates that support safe, consistent delivery.

What is AMI Eyes?

AMI Eyes is a PDRN-based under-eye skin booster derived from salmon DNA. The treatment targets the periorbital area – the delicate skin surrounding the eyes – to address cosmetic concerns including dark circles, tear trough hollowing, under-eye puffiness, fine lines, and skin laxity.

Unlike traditional dermal fillers that add volume, AMI Eyes stimulates the skin’s own collagen production and improves hydration through the regenerative properties of polynucleotides.

The mechanism of action relies on PDRN’s biocompatibility and its proven ability to trigger fibroblast activity, increase hyaluronic acid synthesis, and promote tissue repair. This makes it particularly suitable for the thin, reactive periorbital skin where traditional fillers carry higher risks of bruising, swelling, or visible nodules.

Key ingredients and composition

Understanding the exact composition of AMI Eyes is critical for your treatment documentation and patient informed consent. Each 2ml syringe of AMI Eyes contains a precisely formulated solution of polynucleotides derived from salmon DNA, combined with a stabilizing agent and saline vehicle.

Record the product batch number, expiration date, and storage conditions in your patient’s structured patient records at the time of treatment. This documentation is essential for traceability and regulatory compliance if any adverse events are reported.

Clinical indications: What AMI Eyes treats

AMI Eyes is indicated for a range of periorbital aesthetic concerns. These indications form the basis of your consent form’s patient screening section and help practitioners identify suitable candidates during consultation.

• Dark circles and periorbital hyperpigmentation – the most common patient concern; PDRN-induced collagen and hydration improvements can reduce the shadowing appearance
• Tear trough hollowing – volume loss under the eyes; PDRN stimulation addresses this through tissue regeneration rather than bolus filling
• Under-eye puffiness and edema – PDRN’s regenerative properties can improve lymphatic drainage and skin elasticity
• Fine lines and periorbital wrinkles – improved hydration and collagen synthesis smooth the eye contour area
• Skin laxity around the eye – treatment tightens and firms the delicate periorbital skin over the course of multiple sessions

During patient consultation, confirm that the patient’s primary concern falls within these indications. Use your digital consent templates to document which specific indication the patient seeks treatment for. This becomes part of the informed consent record and supports your medical-legal documentation.

AMI Eyes injection technique and anatomical injection points

Safe, consistent AMI Eyes delivery depends on mastering the injection technique and understanding the anatomy of the periorbital region. The under-eye area has unique vascular and nerve anatomy, so improper injection depth or placement can cause bruising, ecchymosis, or aesthetic irregularities.

Practitioners should inject AMI Eyes using a micro-injection technique with a 32G or 30G needle, targeting the superficial dermis at a 15-30 degree angle. Key injection zones include the tear trough area (medial aspect of the lower lid), lateral canthus (crow’s feet region), and the periorbital skin at the orbital margin.

Avoid injection directly into the muscle or subcutaneous fat. Superficial dermal placement ensures optimal PDRN activity and minimizes complications.

Document the exact injection points and technique in your clinical notes using injection mapping tools tools. Recording the number of injection points, depth, angle, and any patient reactions creates a detailed audit trail and supports continuity of care across multiple treatment sessions.

Treatment protocol: Sessions, dosage, and intervals

AMI Eyes follows a structured multi-session protocol. Most practitioners deliver 3 treatment sessions spaced 2-4 weeks apart. Each session uses the full 2ml syringe, administered via micro-injections distributed across the periorbital area. The table below shows timing as cumulative weeks from baseline, not the interval between individual sessions.

Document each session date, dosage used, batch number, and any observations in the patient’s timeline. Automated treatment workflows can help you schedule follow-up sessions and send appointment reminders, ensuring patients complete the full protocol for optimal results.

Benefits and expected outcomes

Patients seek AMI Eyes treatment for visible, measurable improvements in the eye area. Realistic outcome expectations support informed consent and patient satisfaction. Results typically emerge gradually over the 8-week treatment course and continue to improve in the weeks following the final session as collagen remodeling progresses.

• Reduction in dark circles – improved skin hydration and blood flow create a brighter, more rested appearance within 2-4 weeks
• Softening of fine lines – increased collagen density and hyaluronic acid synthesis smooth periorbital wrinkles by 4-8 weeks
• Improved skin texture and radiance – PDRN stimulation enhances overall skin quality, with a visible glow by the third session
• Reduced tear trough hollowing – tissue repair and collagen buildup restore volume lost to aging, reducing the sunken appearance
• Tighter, firmer skin – skin laxity improvement is visible over weeks 6-12 as the regenerative process matures

Set realistic timelines during consultation. While some patients see subtle improvements after session 1, the most dramatic results emerge after session 3 and continue through weeks 12-16 post-treatment. Documenting baseline photos (with consent) and follow-up images at weeks 4, 8, and 12 provides objective evidence of treatment efficacy and strengthens your clinical record.

Contraindications and safety considerations

Safe AMI Eyes delivery requires thorough screening for contraindications. Your consent form must include a detailed contraindication checklist covering absolute and relative contraindications.

Absolute contraindications (do NOT treat):

• Known or suspected allergy to salmon, fish proteins, or PDRN
• Active infection, herpes simplex, or other viral lesions in the periorbital area
• Recent (<6 weeks) surgical procedures, laser treatments, or chemical peels in the eye area
• Pregnancy or breastfeeding (PDRN safety in pregnancy is not established)
• Severe immunosuppression or immunocompromise
• Anticoagulant therapy or bleeding disorders (relative – assess benefit vs risk)

Relative contraindications (assess risk; caution advised):

• Recent (<2 weeks) botulinum toxin or dermal filler injection in the eye area
• Chronic inflammatory skin conditions (rosacea, severe eczema)
• Tendency to keloid or hypertrophic scar formation
• Unrealistic patient expectations or body dysmorphia
• Concurrent retinoid, acid, or vitamin C use (advise pause for 48 hours pre- and post-treatment)

Salmon DNA allergy is the most critical safety concern. While rare, anaphylaxis to PDRN has been reported in fish-allergic patients. Always ask directly during consultation and document the patient’s allergy history in writing.

Your consent form should explicitly state: “I confirm I have no known allergy to salmon, fish proteins, or PDRN and understand that an allergic reaction, including anaphylaxis, is a possible (though rare) risk of this treatment.”

Downloadable AMI Eyes consent form template

A professionally drafted consent form is your primary legal protection and demonstrates duty of care. The downloadable AMI Eyes consent template included with this guide covers all essential elements: treatment description, expected benefits, realistic outcomes, common side effects, rare serious risks (including anaphylaxis), contraindication screening, pre-treatment instructions, post-treatment aftercare, and patient signature/dating.

The template is structured for practice workflow – practitioners can print, hand to the patient during consultation, review point-by-point, and collect a signed copy for the medical record.

Alternatively, use medical spa software with built-in digital consent form capabilities to have patients e-sign the form on a tablet during check-in, automatically linking it to their patient record and creating an immutable audit trail.

Downloadable AMI Eyes patient aftercare instructions

Post-treatment aftercare is crucial for optimal results and patient safety. The downloadable aftercare template guides patients through the critical 48-72 hours post-injection and provides practical hygiene and activity recommendations for the first two weeks, in the same patient-facing format as other Pabau resources like a mindful eating script.

Key aftercare points include:

• Avoid touching or rubbing the treated area for 24 hours
• Minimize heat exposure (saunas, hot showers, intense exercise) for 48 hours
• Sleep elevated on 2-3 pillows to reduce swelling
• Apply cool compresses as needed
• Use a gentle, fragrance-free moisturizer
• Avoid retinoids, acids, and vitamin C for 48 hours
• Take over-the-counter ibuprofen for minor discomfort
• Avoid alcohol and blood thinners for 24 hours

Use automated aftercare messages to send the written aftercare sheet and a follow-up reminder 48 hours post-treatment, reinforcing compliance and demonstrating attentive patient care. This automation reduces admin burden and improves patient satisfaction scores.

How to manage AMI Eyes treatments with Pabau

Practice management software like Pabau connects AMI Eyes product knowledge to day-to-day clinical operations. Within Pabau, you can create a custom “AMI Eyes Treatment” service, link the downloadable consent form template to the service, and attach pre-treatment instructions. When a patient books an AMI Eyes appointment online, they receive a pre-treatment checklist via SMS or email 48 hours before arrival.

On treatment day, pull up the patient’s record and use Pabau’s AI-powered clinical documentation to record the session: injection points, depth, technique, batch number, dosage, and any reactions. The system auto-saves and timestamps each entry, creating a medico-legal audit trail. After the session, trigger the automated aftercare email containing the downloadable aftercare sheet and a 48-hour check-in reminder.

For session scheduling: use Pabau’s appointment automation to book the follow-up session at the 2-4 week mark automatically during the first visit check-out. This ensures patients don’t miss the optimal treatment window and complete the full 3-session protocol.

Storage, handling, and shelf life

Improper storage degrades PDRN efficacy and compromises patient safety. AMI Eyes is room-temperature stable and should be stored at approximately 1-30°C, in the original, sealed packaging, kept cool and away from direct light. Do NOT freeze. Check the expiration date before each use, and discard any product beyond the printed expiry date.

Once opened or punctured, use the syringe immediately. Do NOT store a partially used syringe for future sessions — each treatment uses a fresh 2ml syringe. Maintaining accurate storage and handling records supports regulatory compliance, particularly if your practice is subject to Care Quality Commission (CQC) inspection.

Document the batch number, storage date, and expiration on each syringe label in your patient’s record. This traceability is essential if any adverse events are reported and must be traced to a specific product batch.

Why downloadable templates matter for your practice

Professional consent forms, treatment protocols, and aftercare templates demonstrate clinical rigor and protect your practice from regulatory and liability risk. They signal to patients that you take safety seriously and have standardized, evidence-based processes in place. Pabau’s downloadable template library spans well beyond aesthetics too, from a CBT cheat sheet to an apathy evaluation scale for other specialties.

Whether you print templates on paper or deliver them digitally via patient portal, having a consistent, legally sound template for every aesthetic treatment is non-negotiable in 2026.

Conclusion

AMI Eyes is a powerful PDRN treatment for periorbital rejuvenation, but it demands meticulous documentation and patient safety screening. The downloadable consent form and aftercare template provided with this guide cover all essential clinical and legal elements, from contraindication screening to post-treatment expectations.

By combining the template with structured practice management software, you transform isolated product knowledge into a systematic, auditable clinical workflow that protects both your patients and your practice.

Continue your research

Need a comprehensive patient consent framework? Facial consent form template walk through best practice consent wording for all aesthetic procedures.

Want to automate treatment follow-ups? Aesthetic consultation forms guide practitioners on documenting consultations in a way that supports seamless treatment scheduling.

Looking to streamline patient records? Med spa consultation forms provide ready-to-use structures for initial patient intake and risk assessment.

Frequently asked questions